Cargando…
New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease resulting from the interaction of genetic and environmental factors. In addition, some antiviral vaccines have been associated with the onset of SLE. Few cases of SLE occurring after SARS-CoV-2 mRNA have been reported. Herein, we...
Autores principales: | Báez-Negrón, Laisha, Vilá, Luis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856802/ https://www.ncbi.nlm.nih.gov/pubmed/35186342 http://dx.doi.org/10.1155/2022/6436839 |
Ejemplares similares
-
Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination
por: Rimmer, Sarah, et al.
Publicado: (2023) -
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
por: Mormile, Ilaria, et al.
Publicado: (2022) -
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
por: Yoshida, Tsuneyasu, et al.
Publicado: (2022) -
SARS-CoV-2 and Systemic Lupus Erythematosus
por: Thanou, Aikaterini, et al.
Publicado: (2021) -
Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)()
por: Anuforo, Anderson, et al.
Publicado: (2022)